Details for New Drug Application (NDA): 216932
✉ Email this page to a colleague
The generic ingredient in ALYQ is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 216932
Tradename: | ALYQ |
Applicant: | Teva Pharms Inc |
Ingredient: | tadalafil |
Patents: | 0 |
Pharmacology for NDA: 216932
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 216932
Suppliers and Packaging for NDA: 216932
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALYQ | tadalafil | TABLET;ORAL | 216932 | ANDA | Teva Pharmaceuticals, Inc. | 0480-9277 | 0480-9277-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-9277-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Oct 12, 2022 | TE: | AB2 | RLD: | No |
Complete Access Available with Subscription